Join        Login             Stock Quote

Covidien (COV) Raises Revenue View After Better-Than-Expected 1Q

 January 25, 2013 06:57 AM

(By Balachander) Covidien Plc (NYSE: COV) posted better-than-expected quarterly earnings helped by strong sales growth at its medical devices segment and the Ireland-based developer of healthcare products lifted its outlook for 2013.

Excluding items, earnings per share declined 2.7 percent to $1.10, beating Wall Street projections of $1.06.

Net earnings were nearly flat at $493 million for the first quarter.

Sales increased 5.5 percent to $3.06 billion, better than consensus estimate of a growth of 3.40 percent. Medical devices sales increased 8 percent, while pharmaceuticals sales were flat. Medical supplies sales grew 2 percent.

[Related -S&P Buys That Pass The Buffett Test]

Covidien said it continued to generate above-market growth in a number of key categories at its medical devices segment, including stapling, energy, airway and ventilation.

Gross margin shrank 1.2 percentage points to 57.5 percent. Non-GAAP declined 1.3 percentage points to 57.5 percent.

Selling, general and administrative expenses increased 3.7 percent and Research and development expenses also rose 3.5 percent.

Looking ahead for the full year, the company now forecasts net sales growth between 5 percent and 8 percent versus 3 percent to 6 percent rise projected earlier, while analysts expect an increase of 4.70 percent.

COV shares, which have been trading in the 52-week range of $48.22 to $61.69, ended at $61.67 on Thursday.

iOnTheMarket Premium


Post Comment -- Login is required to post message
Alert for new comments:
Your email:
Your Website:

rss feed

Latest Stories

article imageEmerging-Markets Stocks Took The Lead Last Week

Emerging-markets equities enjoyed a solid rise last week among the major asset classes, based on a set of read on...

article imageDoes Your Latest Investment Pass This Test?

On Wednesday, I sounded the alarm about the problems looming for some consumer staples stocks. In short, read on...

article imageIs The Slump In US Manufacturing Easing?

Yesterday’s November survey data from the Philadelphia Fed hints at the possibility that a stronger trend read on...

article imageMarket Potentially Facing Near Term Technical Headwinds

After the S&P 500 Index pullback on Thursday and Friday last week, the market's advance on Monday and read on...

Popular Articles

Daily Sector Scan
Partner Center

Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.